[ad_1]
(HealthDay)—An increased risk for nonfatal drug-related poisoning is associated with benzodiazepine treatment in patients with opioid use disorder, according to a study published online March 3 in The American Journal of Psychiatry.
Kevin Y. Xu, M.D., from the Washington University School of Medicine in St. Louis, and colleagues used data from the IBM MarketScan database (2006 to 2016) to identify prescription claims in persons (aged 12 to 64 years) with opioid use disorder who were prescribed buprenorphine and who experienced drug-related poisoning.
The researchers found that buprenorphine treatment days were associated with a reduction in the risk for poisoning events (odds ratio [OR], 0.63) relative to nontreatment days. Benzodiazepine treatment days were associated with an increase in the risk for such events (OR, 1.88). There was an increase seen in poisonings associated with low-dose (OR, 1.78) and high-dose benzodiazepine treatment (OR, 2.22). High-dose benzodiazepine treatment was associated with increased poisonings in combination with buprenorphine cotreatment (OR, 1.64), but this was lower than the risk associated with benzodiazepine treatment in the absence of buprenorphine (ORs, 1.69 and 2.23 for low-dose and high-dose, respectively).
“Dose reduction of benzodiazepines while maintaining buprenorphine treatment may have the advantage of lowering drug-related poisoning risk,” the authors write.
Opioid overdose reduced in patients taking buprenorphine
Abstract/Full Text (subscription or payment may be required)
Copyright © 2021 HealthDay. All rights reserved.
Citation:
Benzodiazepines up risk for nonfatal drug-related poisoning in OUD (2021, April 2)
retrieved 3 April 2021
from https://medicalxpress.com/news/2021-04-benzodiazepines-nonfatal-drug-related-poisoning-oud.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- WHO’s technical advisory group to meet on Oct 26 to consider Covaxin - October 19, 2021
- 163 oxygen plants set up in MP after shortage during 2nd COVID-19 wave: CM Shivraj Singh Chouhan - October 19, 2021
- India’s R-value below 1 since September, researchers say - October 19, 2021
- Mumbai: Double vaccine jab not mandatory to enter theatres, colleges to reopen with 50% attendance - October 19, 2021
- Daily exercise routine, balanced diet, active lifestyle & quality sleep key to success in personal & professional lives: Experts - October 19, 2021
- Storia® Food & Beverages gets backed by Sixth Sense Ventures - October 19, 2021
- No COVID-19 death in Mumbai for first time almost since pandemic began - October 18, 2021
- New govt hospital to come up in Delhi’s Shalimar Bagh - October 18, 2021
- Mix-and-match vaccines highly effective against COVID-19: Lancet - October 18, 2021
- Self-reliance: Govt aims to make semiconductors in India by mid-2022 - October 18, 2021
